T. Kaname, K. Yanagi, and K. Naritomi, A commentary on the promise of wholeexome sequencing in medical genetics, J Hum Genet, vol.59, pp.117-125, 2014.

J. Majewski, J. Schwartzentruber, E. Lalonde, A. Montpetit, and N. Jabado, What can exome sequencing do for you, J Med Genet, vol.48, pp.580-589, 2011.

G. J. Lyon and J. O'rawe, Human genetics and clinical aspects of neurodevelopmental disorders, The Genetics of Neurodevelopmental Disorders, vol.2015, pp.289-317

S. N. Hart, V. Sarangi, R. Moore, S. Baheti, J. D. Bhavsar et al., SoftSearch: integration of multiple sequence features to identify breakpoints of structural variations, PLoS One, vol.8, p.83356, 2013.

R. J. Lonigro, C. S. Grasso, D. R. Robinson, X. Jing, Y. Wu et al., Detection of somatic copy number alterations in cancer using targeted exome capture sequencing, Neoplasia, vol.13, pp.1019-1040, 2011.

D. Liang, Y. Peng, W. Lv, L. Deng, Y. Zhang et al., Copy number variation sequencing for comprehensive diagnosis of chromosome disease syndromes, J Mol Diagn, vol.16, pp.519-545, 2014.

P. S. Samarakoon, H. S. Sorte, B. E. Kristiansen, T. Skodje, Y. Sheng et al., Identification of copy number variants from exome sequence data, BMC Genomics, vol.15, p.661, 2014.

L. Sastre, Exome sequencing: what clinicians need to know, Adv Genomics Genet, vol.4, pp.15-27, 2014.

S. Jayadev, C. O. Smith, and T. D. Bird, Neurogenetics: five new things, Neurol Clin Pract, vol.1, pp.41-49, 2011.

D. B. Jackson and A. K. Sood, Personalized cancer medicine-advances and socioeconomic challenges, Nat Rev Clin Oncol, vol.8, pp.735-776, 2011.

S. M. Jamal, J. Yu, J. X. Chong, K. M. Dent, J. H. Conta et al., Practices and policies of clinical exome sequencing providers: analysis and implications, Am J Med Genet A, vol.161, pp.935-50, 2013.

A. Pokorska-bocci, M. Kroese, G. S. Sagoo, A. Hall, and H. Burton, Personalised medicine in the UK: challenges of implementation and impact on healthcare system, Genome Med, vol.6, p.28, 2014.

V. T. Devita, A. Eggermont, S. Hellman, and D. J. Kerr, Clinical cancer research: the past, present and the future, Nat Rev Clin Oncol, vol.11, pp.663-672, 2014.

J. Taber, K. A. Dickinson, B. D. Wilson, and M. , The promise and challenges of next-generation genome sequencing for clinical care, JAMA Intern Med, vol.174, pp.275-80, 2014.

A. L. Mcguire, B. M. Knoppers, M. H. Zawati, and E. W. Clayton, Can I be sued for that? Liability risk and the disclosure of clinically significant genetic research findings, Genome Res, vol.24, pp.719-742, 2014.

R. C. Green, J. S. Berg, W. W. Grody, S. S. Kalia, B. R. Korf et al., ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing, Genet Med, vol.15, pp.565-74, 2013.

M. Allyse and M. Michie, Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing, Trends Biotechnol, vol.31, pp.439-480, 2013.

A. Townsend, S. Adam, P. H. Birch, and J. M. Friedman, Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard, Genet Med, vol.15, pp.751-753, 2013.

J. B. Mccormick, R. R. Sharp, G. Farrugia, N. M. Lindor, D. Babovic-vuksanovic et al., Genomic medicine and incidental findings: balancing actionability and patient autonomy, Mayo Clin Proc, vol.89, pp.718-739, 2014.

E. Vayena and J. Tasioulas, Genetic incidental findings: autonomy regained, Genet Med, vol.15, pp.868-70, 2013.

. Acmg-board and . Directors, ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing, Genet Med, vol.17, pp.68-69, 2014.

J. Y. Hehir-kwa, M. Claustres, R. J. Hastings, C. Van-ravenswaaij-arts, G. Christenhusz et al., Towards a European consensus for reporting incidental findings during clinical NGS testing, Eur J Hum Genet, vol.23, p.1601, 2015.

K. Boycott, T. Hartley, S. Adam, F. Bernier, K. Chong et al., The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists, J Med Genet, vol.52, pp.431-438, 2015.

K. Knobloch, U. Yoon, and P. M. Vogt, Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias, J Craniomaxillofac Surg, vol.39, pp.91-93, 2011.

M. Petticrew and H. Roberts, Systematic reviews in the social sciences: a practical guide, 2006.

S. Elo and H. Kyngäs, The qualitative content analysis process, J Adv Nurs, vol.62, pp.107-122, 2008.

B. Downe-wamboldt, Content analysis: method, applications, and issues, Health Care Women Int, vol.13, pp.313-334, 1992.

A. A. Vorderstrasse, M. J. Hammer, and J. R. Dungan, Nursing implications of personalized and precision medicine, Semin Oncol Nurs, vol.30, pp.130-136, 2014.

E. S. Williams and M. Hegde, Implementing genomic medicine in pathology, Adv Anat Pathol, vol.20, pp.238-282, 2013.

S. L. Merrill, A. Vaidya, and R. E. Pyeritz, Ethical challenges of the use of whole exome sequencing in the clinic, World J Pediatr Congenit Heart Surg, vol.4, pp.58-61, 2013.

A. N. Mayer, D. P. Dimmock, M. J. Arca, D. P. Bick, J. W. Verbsky et al., A timely arrival for genomic medicine, Genet Med, vol.13, pp.195-201, 2011.

F. Girolami, M. Iascone, B. Tomberli, S. Bardi, M. Benelli et al., Novel ?-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study, Circ Cardiovasc Genet, vol.7, pp.741-50, 2014.

T. Takeichi, L. Liu, K. Fong, L. Ozoemena, J. R. Mcmillan et al., Wholeexome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory, Br J Dermatol, vol.172, pp.94-100, 2015.

K. J. Carss, S. C. Hillman, V. Parthiban, D. J. Mcmullan, E. R. Maher et al., Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound, Hum Mol Genet, vol.23, pp.3269-77, 2014.

A. C. Need, V. Shashi, Y. Hitomi, K. Schoch, K. V. Shianna et al., Clinical application of exome sequencing in undiagnosed genetic conditions, J Med Genet, vol.49, pp.353-61, 2012.

E. M. Coonrod, J. D. Durtschi, R. L. Margraf, and K. V. Voelkerding, Developing genome and exome sequencing for candidate gene identification in inherited disorders: An integrated technical and bioinformatics approach, Arch Pathol Lab Med, vol.137, pp.415-448, 2013.

L. Lacroix, A. Boichard, F. André, and J. Soria, Genomes in the clinic: the Gustave Roussy Cancer Center experience, Curr Opin Genet Dev, vol.24, pp.99-106, 2014.

D. Levenson, Whole-exome sequencing emerges as clinical diagnostic tool: Testing method proves useful for diagnosing wide range of genetic disorders, Am J Med Genet Part A, vol.164, pp.ix-x, 2014.

K. N. Lazaridis, T. M. Mcallister, D. Babovic-vuksanovic, S. A. Beck, M. J. Borad et al., Implementing individualized medicine into the medical practice, Am J Med Genet C: Semin Med Genet, vol.166, pp.15-23, 2014.

W. A. Van-zelst-stams, H. Scheffer, and J. A. Veltman, Clinical exome sequencing in daily practice: 1,000 patients and beyond, Genome Med, vol.6, issue.2, 2014.

H. J. Jacob, K. Abrams, D. P. Bick, K. Brodie, D. P. Dimmock et al., Genomics in clinical practice: lessons from the front lines, Sci Transl Med, vol.5, pp.194-199, 2013.

A. Malhotra, S. Levine, and D. Allingham-hawkins, Whole exome sequencing for cancer -is there evidence of clinical utility?, Adv Genomics Genet, vol.4, p.115, 2014.

F. Chang and M. M. Li, Clinical application of amplicon-based next-generation sequencing in cancer, Cancer Genet, vol.206, pp.413-422, 2013.

K. M. Boycott, M. R. Vanstone, D. E. Bulman, and A. E. Mackenzie, Rare-disease genetics in the era of next-generation sequencing: discovery to translation, Nat Rev Genet, vol.14, pp.681-91, 2013.

H. Lee and S. F. Nelson, Rethinking clinical practice: clinical implementation of exome sequencing, Per Med, vol.9, pp.785-792, 2012.

U. Bacher, A. Kohlmann, and T. Haferlach, Mutational profiling in patients with MDS: ready for every-day use in the clinic?, Best Pract Res Clin Haematol, vol.28, pp.32-42, 2015.

H. H. Arts and N. Knoers, Current insights into renal ciliopathies: what can genetics teach us?, Pediatr Nephrol, vol.28, pp.863-74, 2013.

J. S. Berg, J. P. Evans, M. W. Leigh, H. Omran, C. Bizon et al., Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: implications for application to clinical testing, Genet Med, vol.13, pp.218-247, 2011.

A. Sutton and N. H. Robin, Clinical application of whole exome sequencing: not (yet) ready for primetime, Curr Opin Pediatr, vol.24, pp.663-667, 2012.

Y. Xue, A. Ankala, W. R. Wilcox, and M. R. Hegde, Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing, Genet Med, vol.17, issue.6, pp.444-51, 2015.

H. Klein, P. Hambuch, P. Bauer, and T. Hambuch, Whole genome sequencing (WGS), whole exome sequencing (WES) and clinical exome sequencing (CES) in patient care, J Lab Med, vol.38, pp.221-251, 2014.

T. Graubert and R. Stone, AML genomics for the clinician, Semin Hematol, vol.51, pp.322-331, 2014.

W. G. Newman and G. C. Black, Delivery of a clinical genomics service, Genes (Basel), vol.5, pp.1001-1018, 2014.

S. M. Sisodiya, Genetic screening and diagnosis in epilepsy?, Curr Opin Neurol, vol.28, pp.136-178, 2015.

A. J. Marian, Sequencing your genome: what does it mean?, Methodist Debakey Cardiovasc J, vol.10, pp.3-6, 2014.

R. L. Gillespie, G. Hall, and G. C. Black, Genetic testing for inherited ocular disease: delivering on the promise at last?, Clin Experiment Ophthalmol, vol.42, pp.65-77, 2014.

V. G. Sankaran and P. G. Gallagher, Applications of high-throughput DNA sequencing to benign hematology, Blood, vol.122, pp.3575-82, 2013.

J. D. Jongbloed, A. Pósafalvi, W. S. Kerstjens-frederikse, R. J. Sinke, and J. P. Van-tintelen, New clinical molecular diagnostic methods for congenital and inherited heart disease, Expert Opin Med Diagn, vol.5, pp.9-24, 2011.

X. Lin, W. Tang, S. Ahmad, J. Lu, C. C. Colby et al., Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities, Hear Res, vol.288, pp.67-76, 2012.

S. Topper, C. Ober, and S. Das, Exome sequencing and the genetics of intellectual disability, Clin Genet, vol.80, pp.117-143, 2011.

A. N. Desai and J. A. , Next-generation sequencing: ready for the clinics?, Clin Genet, vol.81, pp.503-513, 2012.

F. Thomas, C. Desmedt, P. Aftimos, and A. Awada, Impact of tumor sequencing on the use of anticancer drugs, Curr Opin Oncol, vol.26, pp.347-56, 2014.

A. M. Rossor, J. M. Polke, H. Houlden, and M. M. Reilly, Clinical implications of genetic advances in Charcot-Marie-Tooth disease, Nat Rev Neurol, vol.9, pp.562-71, 2013.

B. Rabbani, M. Tekin, and N. Mahdieh, The promise of whole-exome sequencing in medical genetics, J Hum Genet, vol.59, pp.5-15, 2014.

M. A. Ream and M. A. Mikati, Clinical utility of genetic testing in pediatric drugresistant epilepsy: a pilot study, Epilepsy Behav, vol.37, pp.241-249, 2014.

V. Nigro and G. Piluso, Next generation sequencing (NGS) strategies for the genetic testing of myopathies, Acta Myol, vol.31, pp.196-200, 2012.

S. Shkedi-rafid, S. Dheensa, G. Crawford, A. Fenwick, and A. Lucassen, Defining and managing incidental findings in genetic and genomic practice, J Med Genet, vol.51, pp.715-738, 2014.

B. M. Knoppers, M. H. Zawati, and K. Sénécal, Return of genetic testing results in the era of whole-genome sequencing, Nat Rev Genet, vol.16, pp.553-562, 2015.

G. J. Lyon and K. Wang, Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress, Genome Med, vol.4, p.58, 2012.

J. Gecz and M. Corbett, Developmental disorders: deciphering exomes on a grand scale, Lancet, vol.385, pp.1266-1273, 2015.

M. T. Zanolli, V. Khetan, G. Dotan, L. Pizzi, and A. V. Levin, Should patients with ocular genetic disorders have genetic testing?, Curr Opin Ophthalmol, vol.25, pp.359-65, 2014.

C. J. Gallego, C. S. Bennette, P. Heagerty, B. Comstock, M. Horike-pyne et al., Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes, Contemp Clin Trials, vol.39, pp.1-8, 2014.

Y. Jiang, Y. Wang, X. Xiu, K. W. Choy, A. N. Pursley et al., Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era, Crit Rev Clin Lab Sci, vol.51, pp.249-62, 2014.

J. Gibson, S. Young, B. Leng, R. Zreik, and A. Rao, Molecular diagnostic testing of cytology specimens: current applications and future considerations, J Am Soc Cytopathol, vol.3, pp.280-94, 2014.

K. Lohmann and C. Klein, Next generation sequencing and the future of genetic diagnosis, Neurotherapeutics, vol.11, pp.699-707, 2014.

A. Goldberg, C. L. Curtis, and J. A. Kleim, Linking genes to neurological clinical practice: the genomic basis for neurorehabilitation, J Neurol Phys Ther, vol.39, pp.52-61, 2015.

G. Bender, J. Verma, A. Schiffman, and J. D. , Translating genomic discoveries to the clinic in pediatric oncology, Curr Opin Pediatr, vol.27, pp.34-43, 2015.

S. A. Lubitz and P. T. Ellinor, Next-generation sequencing for the diagnosis of cardiac arrhythmia syndromes, Heart Rhythm, vol.12, pp.1062-70, 2015.

V. Fridman and S. M. Murphy, The spectrum of axonopathies: from CMT2 to HSP, Neurology, vol.83, pp.580-581, 2014.

Y. Tang, J. Stahl-herz, and B. A. Sampson, Molecular diagnostics of cardiovascular diseases in sudden unexplained death, Cardiovasc Pathol, vol.23, pp.1-4, 2014.

V. Iacobazzi, V. Infantino, A. Castegna, and G. Andria, Hyperhomocysteinemia: related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues, Mol Genet Metab, vol.113, pp.27-33, 2014.

Z. Liu, H. Li, G. Tan, Q. Tao, W. Ni et al., Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system, Neurobiol Aging, vol.35, pp.2881-2892, 2014.

M. Sanchez, R. L. Levine, and R. Rampal, Integrating genomics into prognostic models for AML, Semin Hematol, vol.51, pp.298-305, 2014.

A. Smith, K. M. Boycott, and O. Jarinova, Clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants, Hum Mutat, vol.2014, issue.35, pp.265-274, 2013.

S. Dacic and M. Nikiforova, Present and future molecular testing of lung carcinoma, Adv Anat Pathol, vol.21, pp.94-103, 2014.

N. Babkina and J. M. Graham, New genetic testing in prenatal diagnosis, Semin Fetal Neonatal Med, vol.19, pp.214-223, 2014.

J. S. Beckmann, Can we afford to sequence every newborn baby's genome?, Hum Mutat, vol.36, pp.283-289, 2015.

J. K. Williams, A. K. Cashion, and D. L. Veenstra, Challenges in evaluating next-generation sequence data for clinical decisions, Nurs Outlook, vol.63, pp.48-50, 2015.

J. S. Berg, Genome-scale sequencing in clinical care: establishing molecular diagnoses and measuring value, JAMA, vol.312, pp.1865-1872, 2014.

V. Shashi, A. Mcconkie-rosell, K. Schoch, V. Kasturi, C. Rehder et al., Practical considerations in the clinical application of whole-exome sequencing, Clin Genet, vol.89, issue.2, pp.173-81, 2016.

P. S. Atwal, M. Brennan, R. Cox, M. Niaki, J. Platt et al., Clinical whole-exome sequencing: are we there yet, Genet Med, vol.16, pp.717-726, 2014.

S. Kamalakaran, V. Varadan, A. Janevski, N. Banerjee, D. Tuck et al., Translating next generation sequencing to practice: opportunities and necessary steps, Mol Oncol, vol.7, pp.743-55, 2013.

G. Matthijs, E. Souche, M. Alders, A. Corveleyn, S. Eck et al., Guidelines for diagnostic next-generation sequencing, Eur J Hum Genet, vol.24, pp.2-5, 2016.

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al., Committee; on behalf of the ACMG Laboratory Quality Assurance. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, pp.405-428, 2015.

L. M. Sabatini, C. Mathews, D. Ptak, S. Doshi, K. Tynan et al., Genomic sequencing procedure microcosting analysis and health economic cost-impact analysis: a report of the association for molecular pathology, J Mol Diagnostics, vol.18, pp.319-347, 2016.

L. M. Amendola, G. P. Jarvik, M. Leo, H. M. Mclaughlin, H. Akkari et al., Performance of ACMG/AMP variant interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research (CSER) consortium, Am J Hum Genet, 2016.

. Acmg-board-of-directors, Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics, Genet Med, vol.17, pp.505-512, 2015.

J. Thevenon, Y. Duffourd, A. Masurel-paulet, M. Lefebvre, F. Feillet et al., Diagnostic odyssey in severe neurodevelopmental disorders: Towards clinical whole-exome sequencing as a first-line diagnostic test, Clin Genet, vol.89, issue.6, pp.700-707, 2016.

T. Vrijenhoek, K. Kraaijeveld, M. Elferink, J. De-ligt, E. Kranendonk et al., Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects, Eur J Hum Genet, vol.23, issue.9, pp.1142-50, 2015.